Micromolar concentrations of PACAP27 (0.1–5 μM) and a high-affinity selective PAC1 receptor agonist, maxadilan (1–2 μM), did not significantly affect the viability of Y-79 human retinoblastoma cells. Here, ADCYAP1R1 is linked to retinoblastoma.